Back to top

Image: Bigstock

Top Ranked Momentum Stocks to Buy for May 20th

Read MoreHide Full Article

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 20th:

Mersana Therapeutics, Inc. (MRSN - Free Report) : This clinical stage biopharmaceutical company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 14.8% over the last 60 days.

Mersana Therapeutics, Inc. Price and Consensus

Mersana's shares gained 9.6% over the last one month compared to S&P 500’s rise of 1.7%. The company possesses a Momentum Score of B.

Mersana Therapeutics, Inc. Price

InterDigital, Inc. (IDCC - Free Report) : This designer and developer of technologies that enable and enhance wireless communications has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 48% over the last 60 days.

InterDigital, Inc. Price and Consensus

InterDigital’s shares gained 17.3% over the last one month. The company possesses a Momentum Score of B.

InterDigital, Inc. Price

Atlas Air Worldwide Holdings, Inc. : This provider of outsourced aircraft and aviation operating services has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 27.1% over the last 60 days.

Atlas Air Worldwide Holdings Price and Consensus

Atlas Air's shares gained 56.8% over the last one month. The company possesses a Momentum Score of B.

Atlas Air Worldwide Holdings Price

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


InterDigital, Inc. (IDCC) - free report >>

Mersana Therapeutics, Inc. (MRSN) - free report >>

Published in